Corstrata was founded to deliver innovative wound prevention and management to address the shortage of expertise in the $33B U.S. wound care market. Healthcare providers – home health agencies, hospices, skilled nursing facilities, rehab hospitals etc. and payers – self-insured employers, Accountable Care Organizations (ACOs), Medicare Advantage plans, etc. benefit from Corstrata’s unique combination of clinical expertise, mobile digital technologies and telehealth to treat and prevent patient wounds and to support practitioners anywhere, any time.
Corstrata delivers an array of services ranging from comprehensive wound management to individual wound patient consultations and specific services such as formulary design, treatment guidelines assessment, wound documentation review, and clinical education. Additionally, Corstrata offers a Lower Extremity Amputation Prevention (LEAP) Program which uses an innovative telehealth platform with leading edge infrared thermography to prevent diabetic foot complications. It is a “first in class” solution that reduces the economic burden associated with lower limb complications in high-risk diabetics across the healthcare continuum.